What are the second-line treatment options for immune thrombocytopenia (ITP)?

Updated: Jan 11, 2020
  • Author: Craig M Kessler, MD, MACP; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

TPO-RA and rituximab are second-line options for patients with ITP lasting 3 months or more and in those who are corticosteroid dependent or have no response to corticosteroids. For adults who have had ITP for longer than 12 months, splenectomy is also a second-line option.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!